CITICLAV- 457 (WFI)
Trusted Pediatric Antibiotic by Citric Labs
CITICLAV-457 WFI is a highly effective antibiotic oral suspension formulated with Amoxycillin 400 mg and Clavulanic Acid 57 mg to provide powerful protection against a wide range of bacterial infections in children. This hot-selling pediatric formulation is designed for fast recovery, better bacterial resistance control, and improved patient compliance.
Composition
- Amoxycillin 400 mg
- Clavulanic Acid 57 mg
- Oral Suspension with Sterile Water (WFI)
Key Benefits
- Effective against a wide range of bacterial infections
- Helps combat antibiotic-resistant bacteria
- Fast-acting pediatric antibiotic formulation
- Better absorption and improved effectiveness
- Comes with sterile water for easy preparation
Product Description
CITICLAV-457 WFI by Citric Labs is a broad-spectrum antibiotic dry syrup specially developed for pediatric use. The combination of Amoxycillin and Clavulanic Acid helps fight infection-causing bacteria effectively, including bacteria resistant to regular antibiotics. It is widely prescribed for respiratory tract infections, ear infections, throat infections, urinary tract infections, skin infections, and sinus infections.
Related products
Why Choose Citric Labs for PCD Pharma Franchise?
- High-quality WHO-GMP certified products
- Monopoly-based PCD Pharma Franchise opportunities
- Strong product portfolio including pain management range
- Competitive pricing & high margins
- Reliable supply chain across India
